Omeros reported $8.84M in Trade Creditors for its fiscal quarter ending in June of 2025.





Trade Creditors Change Date
Adma Biologics USD 35.66M 3.94M Sep/2026
Alnylam Pharmaceuticals USD 135.4M 27.38M Sep/2026
BioMarin Pharmaceutical USD 946.11M 32.44M Sep/2026
Cytokinetics USD 25.96M 5.45M Sep/2026
Gilead Sciences USD 934M 260M Sep/2026
Heron Therapeutics USD 8.38M 3.27M Sep/2026
Immunic USD 10.12M 2.54M Sep/2026
Insmed USD 84.3M 9.75M Sep/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
MacroGenics USD 3.14M 300K Sep/2026
Omeros USD 8.84M 4.42M Jun/2025
Pfizer USD 4.07B 511M Sep/2026
Rockwell Medical USD 1.5M 423K Jun/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sarepta Therapeutics USD 45.7M 5.28M Sep/2026
United Therapeutics USD 520.2M 22.4M Sep/2026
Vertex Pharmaceuticals USD 3.71B 99.2M Sep/2026